Skip to main content

Table 1 Patient’s characterization and medication profile

From: Effects of neuromuscular electrostimulation in patients with heart failure admitted to ward

  Control Intervention
Etiology N (%)
  Ischemic 04 (40%) 04 (40%)
  Non Ischemic 06 (60%) 06 (60%)
NYHA functional class (%)
  I 0 0
  II 06 (60%) 06 (60%)
  III 04 (40%) 04 (40%)
Sex (%)
  Male 06 (60%) 06 (60%)
  Female 04 (40%) 04 (40%)
Age (years, mean ±SD) 49,5±14,3 52,2±9
LVEF (%, mean ±SD) 38,2±8,8 37,6±6,9
Current medications:
  Diuretics 10 (100%) 10 (100%)
  Digitalis 05 (50%) 04 (40%)
  Betablocker 10 (100%) 09 (90%)
  Vasodilator 02 (20%) 04 (40%)
  Ca2+channel blocker 01 (10%) 01 (10%)
  Anti-arrhythmic 01 (10%) ---
  1. NYHA= New York Heart Association, LVEF= Left ventricular ejection fraction (echo), ACE= Angiotensin Converting Enzyme.